Zobrazeno 1 - 10 of 162 pro vyhledávání: '"Hx, Shi"'
3
Akademický článek
[Selected donor CD34(+) cell boosts for salvage treatment of poor graft function following allogeneic hematopoietic stem cell transplantation in primary myelofibrosis: 3 cases report].
Autor: Shi HX; Department of Hematology, Shanghai Zhaxin Traditional Chinese and Western Medicine Hospital, Shanghai 200443, China., Liu HX; Department of Hematology, Shanghai Zhaxin Traditional Chinese and Western Medicine Hospital, Shanghai 200443, China., Wei DL; Department of Hematology, Shanghai Zhaxin Traditional Chinese and Western Medicine Hospital, Shanghai 200443, China., Zhu J; Department of Hematology, Shanghai Zhaxin Traditional Chinese and Western Medicine Hospital, Shanghai 200443, China., Shao S; Department of Hematology, Shanghai Zhaxin Traditional Chinese and Western Medicine Hospital, Shanghai 200443, China., Jiang Y; Department of Hematology, Shanghai Zhaxin Traditional Chinese and Western Medicine Hospital, Shanghai 200443, China., Wang C; Department of Hematology, Shanghai Zhaxin Traditional Chinese and Western Medicine Hospital, Shanghai 200443, China., Zhao CX; Department of Hematology, Shanghai Zhaxin Traditional Chinese and Western Medicine Hospital, Shanghai 200443, China.
Publikováno v: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2024 Aug 14; Vol. 45 (8), pp. 785-788.
Zobrazit plný text záznamu
4
Akademický článek
A complete oral regimen for induction therapy of patients with high-risk APL: An oral etoposide instead of intravenous infusion for cytoreductive chemotherapy.
Autor: Tang FF; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China., Duan WB; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China., Liu XH; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China., Lu SY; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China., Zhao XS; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China., Qin YZ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China., Jia JS; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China., Wang J; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China., Gong LZ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China., Jiang Q; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China., Zhao T; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China., Shi HX; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China., Chang YJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China., Huang XJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China.; Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China., Jiang H; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China.
Publikováno v: British journal of haematology [Br J Haematol] 2024 Aug; Vol. 205 (2), pp. 510-516. Date of Electronic Publication: 2024 Apr 26.
Zobrazit plný text záznamu
5
Akademický článek
Targeting DKK1 enhances the antitumor activity of paclitaxel and alleviates chemotherapy-induced peripheral neuropathy in breast cancer.
Autor: Shi HX; Institute of Chemical Biology, School of Pharmacy, Henan University, N. Jinming Ave, Kaifeng, 475004, China.; Department of Gastrointestinal Surgery, Huaihe Hospital of Henan University, Kaifeng, 475004, China., Tao HT; Institute of Chemical Biology, School of Pharmacy, Henan University, N. Jinming Ave, Kaifeng, 475004, China., He JJ; Department of Pharmacy, The First Affiliated Hospital of Henan University, Kaifeng, 475004, China., Zhu FY; Institute of Chemical Biology, School of Pharmacy, Henan University, N. Jinming Ave, Kaifeng, 475004, China., Xie CQ; Institute of Chemical Biology, School of Pharmacy, Henan University, N. Jinming Ave, Kaifeng, 475004, China., Cheng YN; Institute of Chemical Biology, School of Pharmacy, Henan University, N. Jinming Ave, Kaifeng, 475004, China., Hou LL; Institute of Chemical Biology, School of Pharmacy, Henan University, N. Jinming Ave, Kaifeng, 475004, China., Sun H; Institute of Chemical Biology, School of Pharmacy, Henan University, N. Jinming Ave, Kaifeng, 475004, China., Qin CJ; Department of Gastrointestinal Surgery, Huaihe Hospital of Henan University, Kaifeng, 475004, China. hhyyqcj@163.com., Fang D; Institute of Chemical Biology, School of Pharmacy, Henan University, N. Jinming Ave, Kaifeng, 475004, China. fangdong@henu.edu.cn.; Department of Gastrointestinal Surgery, Huaihe Hospital of Henan University, Kaifeng, 475004, China. fangdong@henu.edu.cn., Xie SQ; Institute of Chemical Biology, School of Pharmacy, Henan University, N. Jinming Ave, Kaifeng, 475004, China. xiesq@henu.edu.cn.; Department of Gastrointestinal Surgery, Huaihe Hospital of Henan University, Kaifeng, 475004, China. xiesq@henu.edu.cn.
Publikováno v: Molecular cancer [Mol Cancer] 2024 Jul 31; Vol. 23 (1), pp. 152. Date of Electronic Publication: 2024 Jul 31.
Zobrazit plný text záznamu
6
Akademický článek
A lasso and random forest model using flow cytometry data identifies primary myelofibrosis.
Autor: Zhang F; Fujian Provincial Key Laboratory on Hematology, Fujian Medical Center of Hematology, Fujian Institute of Hematology, Clinical Research Center for Hematological Malignancies of Fujian Province, Fujian Medical University Union Hospital, Fuzhou, China., Wang YZ; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China., Chang Y; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China., Yuan XY; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China., Shi WH; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China., Shi HX; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China., Shen JZ; Fujian Provincial Key Laboratory on Hematology, Fujian Medical Center of Hematology, Fujian Institute of Hematology, Clinical Research Center for Hematological Malignancies of Fujian Province, Fujian Medical University Union Hospital, Fuzhou, China., Liu YR; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.
Publikováno v: Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2024 Jul; Vol. 106 (4), pp. 272-281. Date of Electronic Publication: 2024 Apr 22.
Zobrazit plný text záznamu
7
Akademický článek
Cytology or Multiparameter Flow Cytometry Positivity in the Cerebrospinal Fluid Before Transplantation is Predictive of Poor Outcomes After Allotransplantation in Acute Myeloid Leukemia Patients.
Autor: Hu LJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China., Fu GM; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China., Zhang YY; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China., Wang YZ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China., Qin YZ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China., Lai YY; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China., Shi HX; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China., Jiang H; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China., Zhang XH; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China., Xu LP; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China., Wang Y; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China., Jiang Q; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China., Huang XJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.; Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China., Chang YJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Publikováno v: Clinical transplantation [Clin Transplant] 2024 Jul; Vol. 38 (7), pp. e15396.
Zobrazit plný text záznamu
8
Akademický článek
Solvation controlled excited-state dynamics in a donor-acceptor phenazine-imidazole derivative.
Autor: Shi HX; School of Chemical Engineering, Lanzhou University of Arts and Science Lanzhou Gansu 730000 China shhx2003@163.com., Bao HW; School of Chemical Engineering, Lanzhou University of Arts and Science Lanzhou Gansu 730000 China shhx2003@163.com., Wu GY; Anhui Province Key Laboratory for Control and Applications of Optoelectronic Information Materials, School of Physics and Electronic Information, Anhui Normal University Wuhu 241002 China wgy@ahnu.edu.cn.
Publikováno v: RSC advances [RSC Adv] 2024 May 28; Vol. 14 (24), pp. 17071-17076. Date of Electronic Publication: 2024 May 28 (Print Publication: 2024).
Zobrazit plný text záznamu
9
Akademický článek
Cardiac effects of deferasirox in transfusion-dependent patients with myelodysplastic syndromes: TELESTO study.
Autor: Sarocchi M; Cardiovascular Disease Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Li J; School of Medicine, Ruijin Hospital, Shanghai Jiao Tong University, Shanghai, China., Li X; Shanghai Sixth People's Hospital, Shanghai, China., Wu D; Jiangsu Institute of Hematology, First Affiliated Hospital of Suzhou University, Suzhou, China., Montaño Figueroa E; Department of Hematology, Hospital General de México Dr Eduardo Liceaga, Mexico City, Mexico., Rodriguez MG; Department of Hematology, Hospital de Especialidades, Centro Médico Nacional La Raza, IMSS, Mexico City, Mexico., Hou M; Department of Hematology, Qilu Hospital, Shandong University, Jinan, China., Finelli C; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy., Shi HX; Peking University People's Hospital, Beijing, China., Xiao Z; Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China., Oliva EN; Hematology Unit, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy., Gercheva Kyuchukova L; Clinical Hematology Clinic, Multiprofile Hospital for Active Treatment 'Sveta Marina', Varna, Bulgaria., Drummond M; Beatson West of Scotland Cancer Centre, Glasgow, UK., Symeonidis A; Hematology Division, Department of Internal Medicine, University of Patras Medical School, Patras, Greece., Velazquez EJ; Yale School of Medicine, Yale University, New Haven, Connecticut, USA., Rivoli G; Hematology and Cellular Therapy, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Izquierdo M; Novartis Pharma AG, Basel, Switzerland., Kolekar Y; Novartis Healthcare Private Limited, Hyderabad, India., Spallarossa P; Cardiovascular Disease Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Angelucci E; Hematology and Cellular Therapy, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Publikováno v: British journal of haematology [Br J Haematol] 2024 May; Vol. 204 (5), pp. 2049-2056. Date of Electronic Publication: 2024 Feb 11.
Zobrazit plný text záznamu
10
Akademický článek
Knowledge, attitude, and practice of medication and its influencing factors among residents in western China: a large-scale cross-sectional study.
Autor: Shi HX; Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China., Tan X; Department of Pharmacy, People's Hospital of Karamay, Karamay Xinjiang, China., Shu JQ; Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China., Zhou J; Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China., Dan SY; Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China., Yang L; Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China., Chen ZL; Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
Publikováno v: Frontiers in medicine [Front Med (Lausanne)] 2024 Feb 19; Vol. 11, pp. 1303672. Date of Electronic Publication: 2024 Feb 19 (Print Publication: 2024).
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje